Photo via Pexels
mRNA Therapeutics Platform
Programmable mRNA molecules that instruct cells to produce specific therapeutic proteins. After proving themselves with COVID vaccines, these platforms are being adapted to treat cancer, heart disease, and rare genetic disorders.
Why It Matters
A single platform could produce personalized cancer vaccines in weeks, turn the body into its own drug factory, and make rare disease treatments economically viable.
Development Stage
More Like This
In-Vivo Gene Editing
CRISPR-based therapies delivered directly into a living patient to fix disease-causing mutations at their source. No need to remove cells, edit them in a lab, and return them.
Liquid Biopsy Diagnostics
Blood tests that detect fragments of tumor DNA, proteins, and exosomes circulating in the bloodstream. A simple draw can screen for dozens of cancer types years before symptoms appear.
Neural-Controlled Prosthetics
Artificial limbs connected directly to the nervous system via implanted electrodes. Users control them with thought alone and receive sensory feedback including pressure, temperature, and texture.
Senolytics and Longevity Drugs
Pharmaceuticals that selectively destroy senescent (zombie) cells that accumulate with age and drive inflammation, tissue damage, and age-related diseases like Alzheimer's and arthritis.
Enjoyed this? Get five picks like this every morning.
Free daily newsletter — zero spam, unsubscribe anytime.